Proteomics Market

The proteomics market is projected to reach USD 67.55 billion by 2031 from USD 39.84 billion in 2026, at a CAGR of 11.1% during the forecast period.

Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Revvity (US), and Illumina, Inc. (US) are the key players in this market.

To know about the assumptions considered for the study download the pdf brochure

These market players have adopted various approaches, including product launches, collaborations, acquisitions, agreements, and expansions, to enhance their market positions. In April 2026, Thermo Fisher entered a strategic collaboration with PRECISE to advance population-scale proteomics. Under the program, the company deployed an integrated proteomics strategy combining Olink Proximity Extension Assay platforms with the Orbitrap Astral mass spectrometry system, supporting precision medicine and longitudinal cohort research.

 In May 2025, Agilent launched the InfinityLab Pro iQ Series, comprising the Pro iQ and Pro iQ Plus systems. The new LC-mass detection platform is designed for analysis of peptides and proteins, along with small molecules and oligonucleotides, and supported applications such as biomolecule characterization, impurity profiling, and mass-based purification across pharmaceutical, biopharmaceutical, and research laboratories.

Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific offers a broad proteomics portfolio spanning mass spectrometry instruments, sample preparation platforms, reagents, separation workflows, and proteomics software. Its offerings support applications such as protein identification, quantification, post-translational modification analysis, biomarker discovery, and translational research. The company emphasizes integrated end-to-end workflows that combine sample preparation, LC-MS analysis, and data interpretation, helping researchers improve throughput, reproducibility, and analytical depth across proteomics studies.

Agilent Technologies, Inc. (US): Agilent Technologies is a key participant in proteomics, with capabilities across liquid chromatography, LC/MS systems, protein analysis platforms, sample preparation, and data analysis software. The company supports proteomics and protein characterization workflows through integrated analytical solutions designed for both discovery and targeted applications. Its portfolio is used in biomarker research, biopharmaceutical analysis, plasma protein studies, and broader omics workflows.

Merck KGaA (Germany): Merck, through its life science business, provides a wide range of products supporting proteomics workflows, particularly in protein sample preparation, protein mass spectrometry, purification, filtration, enzymes, standards, and biomarker assay solutions. Its portfolio supports researchers working in protein extraction, digestion, enrichment, purification, and downstream mass spectrometry-based analysis. The company also offers immunoassay and protein analysis tools that are relevant for biomarker detection and translational research.

Market Ranking

The proteomics market is moderately consolidated, with leading life sciences and analytical instrumentation companies driving innovation and adoption. Key players include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), and Merck KGaA (Germany). Thermo Fisher Scientific offers integrated proteomics solutions across instruments, reagents, sample preparation, and software, supporting comprehensive protein analysis workflows. Agilent Technologies strengthens the market through its capabilities in liquid chromatography, mass spectrometry, protein analysis, and data management tools that enable efficient, high-quality proteomics studies. Merck KGaA contributes through its broad portfolio of reagents, sample-preparation products, purification solutions, and workflow-enabling consumables for protein research and biomarker studies. Collectively, these companies enhance access to advanced proteomics solutions, improve research efficiency, and support the generation of accurate and actionable protein-level insights across pharmaceutical, biotechnology, clinical, and academic research settings.

Related Reports:

Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]